Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bio-Rad Laboratories, Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Equillium (EQ) and Jade Biosciences (JBIO) with bull...

Wall Street Analysts Are Bullish on Top Healthcare Picks

BioVersys AG ( ($CH:BIOV) ) has provided an update. BioVersys AG will present a corporate overview at the H.C. Wainwright 28th Annual Global Invest...

BioVersys Showcases MDR Antibiotic Pipeline at H.C. Wainwright Global Investment Conference

Biosynex SA ( ($FR:ALBIO) ) has provided an announcement. Biosynex announced that co-founder Thierry Paper has resigned from his roles as Deputy Ch...

Biosynex Co-Founder Thierry Paper Steps Down From Executive and Board Roles

Biomm SA ( ($BR:BIOM3) ) just unveiled an announcement. Biomm’s board of directors has approved a private issuance of unsecured, non-convertible de...

Biomm Secures R$88.3 Million Debenture Backstop from Alaska Investimentos

Swedish Orphan Biovitrum AB ( ($SE:SOBI) ) has provided an update. Sobi has completed a directed issue of 223,677 class C shares, subscribed in ful...

Sobi Completes Class C Share Issue to Fund Employee Incentive Programme

BIotrend Cevre ve EnerjI Yatirimlari AS ( ($TR:BIOEN) ) has provided an announcement. Trading in Biotrend’s BIOEN.E shares on Borsa Istanbul has be...

Biotrend Shares Enter Circuit Breaker Call Auction on Borsa Istanbul

In a report released today, Eliana Merle from Barclays maintained a Buy rating on BridgeBio Pharma, with a price target of $157.00. Merle covers th...

Barclays Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK) and Ibio (IBIO) with bullish sen...

An announcement from BioVersys AG ( ($CH:BIOV) ) is now available. BioVersys AG plans to release its half-year 2026 financial results on September ...

BioVersys Sets September 9 Date for Half-Year 2026 Results and Strategic Update

Bridgebio Pharma (($BBIO)) has held its Q2 earnings call. Read on for the main highlights of the call. BridgeBio Pharma’s latest earnings call stru...

BridgeBio Pharma Earnings Call Signals Growth Amid Risks

Some low‑priced stocks are drawing attention from Wall Street thanks to their growth plans and strong sector trends. These names trade under $10 bu...

3 Stocks Under $10 With Over 100% Upside, According to Analysts

BIotrend Cevre ve EnerjI Yatirimlari AS ( ($TR:BIOEN) ) has provided an update. Biotrend Çevre ve Enerji Yatırımları AŞ reported that its operation...

Biotrend Aligns Operations and Financing With Participation Finance Principles

Sabio Holdings ( ($TSE:SBIO) ) has shared an announcement. Sabio Holdings has secured a US$1.5 million non-revolving term loan facility through its...

Sabio Secures US$1.5 Million High-Interest Term Loan to Support Working Capital

BIotrend Cevre ve EnerjI Yatirimlari AS ( ($TR:BIOEN) ) just unveiled an announcement. Grant Thornton has conducted a limited review of Biotrend Çe...

Biotrend’s 2026 Interim Results Undergo Limited External Review

The latest announcement is out from BIotrend Cevre ve EnerjI Yatirimlari AS ( ($TR:BIOEN) ). Biotrend Çevre ve Enerji Yatırımları AŞ has released i...

Biotrend Publishes 2026 Interim Activity Report Detailing Operations and Governance

BIotrend Cevre ve EnerjI Yatirimlari AS ( ($TR:BIOEN) ) has provided an update. Biotrend Çevre ve Enerji Yatırımları AŞ operates in Türkiye’s envir...

Biotrend Audit Committee Confirms Accuracy of H1 2026 Financial Disclosures

BridgeBio Pharma ( ($BBIO) ) has issued an update. On August 13, 2026, BridgeBio Pharma, Inc. and selling stockholder KKR Genetic Disorder L.P. agr...

BridgeBio Pharma announces major secondary share offering

Anadolu Efes Biracilik ve Malt Sanayii A.S. ( ($TR:AEFES) ) just unveiled an announcement. Central Dematerialised System data show that shares in A...

Conversion of Anadolu Efes and Other Turkish Equities Into Tradable Shares

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Orchestra BioMed Holdings (OBIO) and Adagene (ADAG) ...

Jefferies analyst Andrew Tsai maintained a Buy rating on BridgeBio Pharma today and set a price target of $110.00. Tsai covers the Healthcare secto...

Jefferies Sticks to Their Buy Rating for BridgeBio Pharma (BBIO)

Wells Fargo analyst reiterated a Buy rating on BridgeBio Pharma today and set a price target of $102.00. In a report released today, Piper Sandler ...

Wells Fargo Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

Orchestra BioMed Holdings (OBIO) Receives a Buy from Piper Sandler

Piper Sandler analyst Biren Amin maintained a Buy rating on BridgeBio Pharma today and set a price target of $115.00. According to TipRanks, Amin i...

Piper Sandler Remains a Buy on BridgeBio Pharma (BBIO)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Jade Biosciences (JBIO), MoonLake Immunotherapeutics (MLTX) and Q...

Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), MoonLake Immunotherapeutics (MLTX) and Quanterix (QTRX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BridgeBio Pharma (BBIO) and Rocket Pharmaceuticals (...

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Rocket Pharmaceuticals (RCKT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Jade Biosciences (JBIO), Silence Therapeutics (SLN) ...

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

Analysts have been eager to weigh in on the NA sector with new ratings on BioAge Labs, Inc. (BIOA) and Fiserv (FISV). BioAge Labs, Inc. (BIOA) In a...

Analysts’ Opinions Are Mixed on These NA Stocks: BioAge Labs, Inc. (BIOA) and Fiserv (FISV)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rhythm Pharmaceuticals (RYTM), Ultragenyx Pharmaceut...

Analysts’ Top Healthcare Picks: Rhythm Pharmaceuticals (RYTM), Ultragenyx Pharmaceutical (RARE)

In a report released today, Brandon Couillard from Wells Fargo maintained a Hold rating on Bio-Rad Laboratories, with a price target of $330.00. Ac...

Wells Fargo Remains a Hold on Bio-Rad Laboratories (BIO)

Citi analyst Daniel Grosslight maintained a Hold rating on Bio-Rad Laboratories today and set a price target of $330.00. According to TipRanks, Gro...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BIO	$387.90	-0.16%	146.27K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BIO	$387.90	-0.2%	146.27K
3
4
5
6

BIO

Get Bio-Rad Laboratories, Inc. Data in Excel

Get Bio-Rad Laboratories, Inc. Data in Excel